Work

Rituximab Is Safe and Effective for the Treatment of Post Transplant Lymphoproliferative Disease.

Year: 2000

Type: conference-abstract

Source: Transplantation

DOI: 10.1097/00007890-200004271-00803

Authors: John M. Rabkin, Ali J. Olyaei, Christopher L. Corless, Angelo M. de Mattos, Susan L. Orloff, Hugo R. Rosen, Craig R. Nichols

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2322922478

Cites:

Cited by:

Related to: 10